View Item 

Show simple item record

Dopaminergic involvement in attention a novel animal model
dc.contributor.authorKatz, Richard J.en_US
dc.contributor.authorSchmaltz, Kristineen_US
dc.date.accessioned2006-04-07T18:13:13Z
dc.date.available2006-04-07T18:13:13Z
dc.date.issued1981en_US
dc.identifier.citationKatz, R. J., Schmaltz, K. (1981)."Dopaminergic involvement in attention a novel animal model." Progress in Neuro-Psychopharmacology 4(6): 585-590. <http://hdl.handle.net/2027.42/24570>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B73FH-4CVPW47-M/2/6443a67879dddfdd138c5ccc38efa9cfen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/24570
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7220672&dopt=citationen_US
dc.description.abstract1. 1. Adult male outbred albino mice were acutely injected with either of two dopamine (DA) agonists; Apomorphine, a receptor agonist, or Amantadine, a DA releasing agent.2. 2. Both drugs produced dose-related alterations in initial Y-maze behavior, consisting of significantly increased proportions of 2-arm entries.3. 3. This behavior has previously been shown to reflect an abnormal attentional process.4. 4. Thus DA activation may cause sensory perseveration.5. 5. The implications of this finding for DA theories of psychopathology is discussed.en_US
dc.format.extent332772 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleDopaminergic involvement in attention a novel animal modelen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMental Health Research Institute, Department of Psychiatry University of Michigan Medical Center, Ann, Arbor, Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, Department of Psychiatry University of Michigan Medical Center, Ann, Arbor, Michigan, USAen_US
dc.identifier.pmid7220672en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/24570/1/0000852.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0364-7722(81)90099-0en_US
dc.identifier.sourceProgress in Neuro-Psychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0000852.pdf
Size:
324.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.